COMMUNIQUÉS West-GlobeNewswire

World's largest Alzheimer's survey reveals most adults believe a cure will be developed in their lifetime
17/09/2018
From a sample of over 10,000 adults, 62% are worried that they may develop Alzheimer's disease and 91% believe the solution to tackling diseases lies in medical research[1] 79% are willing to take part in medical [...]
Retrophin to Present at Upcoming Investor Conferences
17/09/2018
SAN DIEGO, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that the Company’s management team will present at the following upcoming investor conferences in October: Cantor Global [...]
argenx announces launch of proposed public offering in the United States
17/09/2018
Regulated information - Inside information September 17, 2018, 10:00 PM CEST - 4:00 PM ET Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology company developing [...]
Xenon Pharmaceuticals Announces Closing of its $63.0 Million Public Offering of Common Shares
17/09/2018
BURNABY, British Columbia, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage, neurology-focused biopharmaceutical company, today announced the closing of its previously [...]
Ascendis Pharma A/S Announces Support for Children’s Growth Awareness Week and Day 2018
17/09/2018
COPENHAGEN, Denmark, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technology to address significant unmet medical needs, today [...]
Galapagos issues new shares as result of public offering
17/09/2018
Mechelen, Belgium; 17 September 2018, 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase as a result of a public offering of American Depositary Shares. In [...]
Galapagos announces closing of public offering of American Depositary Shares for gross proceeds of €296.2 million
17/09/2018
Mechelen, Belgium, 17 September 2018, 22.01 CET, regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announced today the closing of its underwritten public offering of 2,961,373 American Depositary Shares [...]
EPSi announces partnership with Ilerasoft
17/09/2018
Adds innovative software technology for hospital capital budgeting to EPSi Platform CHICAGO, Sept. 17, 2018 (GLOBE NEWSWIRE) -- EPSi, Allscripts (NASDAQ: MDRX) flagship budgeting, long-range planning, cost accounting [...]
OrthoPediatrics Corp. Announces First PNP | FEMUR Cases Performed in Australia
17/09/2018
WARSAW, Ind., Sept. 17, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce the first [...]
G1 Therapeutics Announces Proposed Offering of Common Stock
17/09/2018
RESEARCH TRIANGLE PARK, N.C., Sept. 17, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that it has commenced an underwritten public offering of 3,000, [...]
Sanofi: Disclosure of trading in own shares
17/09/2018
Attachment Reporting EN.pdf
Sanofi : Déclaration des transactions sur actions propres
17/09/2018
Pièce jointe Reporting FR.pdf
Ossur Hf : Transactions in relation to share buyback program
17/09/2018
Announcement no. 55/2018 17 September 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the share [...]
Virbac : Operating profit up sharply in the first half of 2018
17/09/2018
Operating profit up sharply in the first half of 2018 CONSOLIDATED DATA AS OF JUNE 30 in € million 2018 2017 2018/2017 Evolution Revenue 430.0 437.5 -1.7% Evolution at constant exchange rates +3.9% Evolution at constant [...]
Virbac :Résultat opérationnel du premier semestre 2018 en nette croissance
17/09/2018
Résultat opérationnel du premier semestre 2018 en nette croissance CHIFFRES CONSOLIDÉS AU 30 JUIN en millions € 2018 2017 Évolution 2018/2017 Chiffre d'affaires 430,0 437,5 -1,7% Évolution à taux de change constants +3, [...]
Virbac: Availability of the half-yearly financial report as of June 30, 2018
17/09/2018
Virbac: Availability of the half-yearly financial report as of June 30, 2018 Public release - September 17, 2018 Virbac announced today that the 2018 half-yearly financial report is now available and has been filed with [...]
Virbac : Mise à disposition du rapport financier semestriel au 30 juin 2018
17/09/2018
Virbac : Mise à disposition du rapport financier semestriel au 30 juin 2018 Communiqué diffusé le 17 septembre 2018 La société annonce avoir mis à la disposition du public et déposé auprès de l'Autorité des marchés [...]
Oxurion NV to present further scientific findings supporting therapeutic potential of THR-317 & THR-687 as promising new therapies for Diabetic Eye Disease at upcoming EURETINA 2018 in Vienna, Austria
17/09/2018
Leuven, Belgium, 17 September 2018 - Oxurion NV (Euronext Brussels: OXUR - formerly known as ThromboGenics), a biopharmaceutical company developing innovative treatments to preserve vision in patients with diseases [...]
Nesvik Pharmaceuticals, Inc., a Subsidiary of BioStem Technologies, Inc., Announces Engagement of The Gnomon Group for Pre-Investigational New Drug Application Strategy
17/09/2018
Pompano Beach, FL, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Nesvik Pharmaceuticals, Inc., a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), focused on the development of [...]

Pages